| Serial Number | 97703809 |
| Word Mark | CANCER ZERO |
| Filing Date | Monday, December 5, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, September 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 16, 2024 |
| Goods and Services | Pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression; pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer |
| Goods and Services | Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders |
| NOT AVAILABLE | "CANCER" |
| Goods and Services | Research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology; research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Molecular, cellular, and genetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders; Development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 3, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | IN8bio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10118 |
| Party Name | IN8bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10118 |
| Event Date | Event Description |
| Tuesday, September 12, 2023 | ASSIGNED TO EXAMINER |
| Thursday, December 8, 2022 | NEW APPLICATION ENTERED |
| Tuesday, January 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 19, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, September 19, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 19, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 19, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 3, 2023 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Monday, October 23, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, October 23, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, October 23, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, October 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 11, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 11, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 16, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, September 9, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, September 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 9, 2024 | SOU EXTENSION 1 FILED |
| Monday, September 9, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, January 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |